Early detection of bowel and breast cancer greatly increase survival rates. However, participation rates in Australia’s national bowel and breast cancer screening programs are low. In addition, Australia’s screening programs are population-based and mostly do not target patients considered to be at higher risk.

The objective of this study was to measure participation and adherence to liver cancer hepatocellular carcinoma surveillance in eligible patients in a community health centre, following support from the Integrated Hepatitis B Service.

This paper provides an overview of data linkage and its relevance to general practice physicians.